Jointly Provided by AffinityCE and CheckRare CE

Supported by an educational grant from Recordati Rare Diseases, Inc.

Start date: October 16, 2023
End date: October 15, 2024
Estimated time to complete: 0.5 hours

Activity Description

This 30-minute CME program highlights the latest clinical research about Cushing’s disease.

Cushing’s disease is caused by an adrenocorticotropic hormone (ACTH)-secreting pituitary tumor that leads to excessive levels of cortisol.

This CME program, hosted by Lisa Nachtigall, MD, Clinical Director, Neuroendocrine & Pituitary Tumor Clinical Center at Massachusetts General Hospital, and Associate Professor of Medicine at Harvard Medical School, provides an overview of the latest clinical research presented at ENDO 2023 involving Cushing’s disease.

Faculty

Lisa Nachtigall, MD
Clinical Director, Neuroendocrine & Pituitary Tumor Clinical Center
Massachusetts General Hospital
Associate Professor of Medicine
Harvard Medical School

Learning Objective

After participating in the activity, learners should be better able to:

• Describe the latest research being presented to better manage individuals with Cushing’s disease and its clinical relevance.
• Share new information with their clinical team.

Disclosure Statement

AffinityCE and CheckRare CE staff, as well as planning and review committees, have no financial interests to disclose and do not recommend the use of products outside of the FDA approved labelling.

Faculty Educators

Dr. Nachtigall discloses the following relevant financial relationships with ineligible companies to disclose:

• Grant Support: Recordati Rare Diseases Inc
• Advisory Board Member: Corcept Pharmaceuticals Ltd

Method of Participation

There are no fees to participate in the activity. Participants must review the activity information including the learning objectives and disclosure statements, as well as the content of the activity. To receive CME credit for your participation, please complete the pre and post-program assessments. Your certificate will be emailed to you in within 30 days.

Physicians

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of AffinityCE and the LDRTC. AffinityCE is accredited by the ACCME to provide continuing medical education for physicians.

AffinityCE designates this enduring activity for a maximum of 0.5 hours of AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Other Professionals

All other health care professionals completing this continuing education activity will be issued a Statement of participation indicating the number of hours of continuing education credit. This may be used for professional education CE credit. Please consult your accrediting organization or licensing board for their acceptance of this CE activity.

Commercial Support

Educational Support for this activity was provided by Recordati Rare Diseases, Inc.

Participation Costs

There is no cost to participate in this CME session. To receive CME credit for your participation, please complete the pre and post-program assessments. Your certificate will be emailed to you within 30 days.

CME Inquiries

For all CME policy-related inquiries, please contact us at ce@affinityced.com.
Send customer support requests to cds_support+ldrtc@affinityced.com.

Copyright

© 2023. This CME-certified activity is held as copyrighted © by AffinityCE and CheckRare CE. Through this notice, AffinityCE and CheckRare CE grant permission of its use for educational purposes only. These materials may not be used, in whole or in part, for any commercial purposes without prior permission in writing from the copyright owner(s).